ESA 4000IU Injection Substitute
Core Claris Lifesciences Ltd
₹601.63
(₹601.63 per unit)
Biocon Ltd
₹957
(₹957.0/ 1ml)
Alniche Life Sciences Pvt Ltd
₹1359
(₹1359.0/ 1ml)
Bioniche Life Sciences Inc
₹1450
(₹1450.0 per unit)
La Renon Healthcare Pvt Ltd
₹1471.5
(₹1471.5/ 1ml)
Zuventus Healthcare Ltd
₹1485.5
(₹1485.5/ 1ml)
Cadila Healthcare Ltd
₹1572
(₹1572.0 per unit)
Zydus Cadila
₹1572
(₹1572.0 per unit)
Johnson & Johnson Pvt Ltd
₹1820
(₹1820.0 per unit)
Intas Pharmaceuticals Ltd
₹1995.5
(₹1995.5/ 1ml)
Celestial Biologicals Ltd
₹1995.5
(₹1995.5/ 1ml)
Lupin Ltd
₹2097.5
(₹2097.5/ 1ml)
Micro Labs Ltd
₹1125
(₹2812.5/ 1ml)
Cipla Ltd
₹1550
(₹3875.0/ 1ml)
Wockhardt Ltd
₹2030
(₹5075.0/ 1ml)

Patients may explore substitutes in the following scenarios:
Before you switch from ESA 4000IU Injection to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - RECOMBINANT HUMAN ERYTHROPOIETIN ALFA-4000IU, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
ESA 4000IU Injection is used to treat anemia caused by chronic kidney illness, cancer, and HIV infection. The detailed uses of ESA 4000IU Injection are as follows:
ESA 4000IU Injection is a blood hormone. It contains Recombinant Human Erythropoietin Alfa used to treat anaemia caused by chronic diseases and anaemia related to kidney disease, cancers, bone marrow disorders, chemotherapy, children and adults on dialysis, and in those due to undergo major bone surgery. ESA 4000IU Injection stimulates the bone marrow to produce more red blood cells. In addition, it also corrects any dysregulated erythropoiesis (RBC formation) and remedies the formation of any defunct precursors of RBC’s, paving the way for healthy red blood cell production. Clinically, ESA 4000IU Injection causes a direct increase in haemoglobin values and reduces the rates and requirement of blood transfusion.
RX
RX
RX
RX
RX
RX
RX
RX